Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Major update to display a government-operation status notice and newer version tag (v3.2.0); removal of an old resource entry (Small cell lung carcinoma) and older version tag (v3.0.2).
    Difference
    2%
    Check dated 2025-10-02T01:24:03.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    - Added: Revision: v3.1.0. - Removed: Genetic and Rare Diseases Information Center resources: Small cell lung carcinoma and Revision: v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-30T13:43:47.000Z thumbnail image
  5. Check
    26 days ago
    Change Detected
    Summary
    Removed several chemical categories and a drug name (Promethazine, various heterocyclic compound classes, and phenothiazines). This narrows the chemical content and named substances on the page.
    Difference
    0.2%
    Check dated 2025-09-23T10:16:47.000Z thumbnail image
  6. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release; the Back to Top element has been removed as a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-16T04:59:34.000Z thumbnail image
  7. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-09T00:41:54.000Z thumbnail image
  8. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with additional medical topics and diagnostic techniques, while removing several previous topics related to lung cancer and various pharmaceutical agents.
    Difference
    6%
    Check dated 2025-09-01T20:41:40.000Z thumbnail image

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.